<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114091</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Secondary bladder amyloidosis</dc:title>
<dc:description xml:lang="en">The bladder involvement is a very unusual fact in systemic amyloidosis. The distinction of primary and systemic amyloidosis disease with bladder involvement (secondary bladder amyloidosis) is important to the urologist. Secondary amyloidosis of the bladder is a rare disease entity (approximately 20 cases published). We document a case of a woman with a large history of rheumatoid arthritis who developed severe macrohematuria. Diagnosis was done by biopsy that revealed amyloidosis, and it was confirmed with an immunohistochemical staining of the specimens that defined the process as amyloid AA (secondary amyloidosis) (AU)</dc:description>
<dc:creator>Hernández Martí, M</dc:creator>
<dc:creator>Benedicto Redón, A</dc:creator>
<dc:creator>Arlandis Guzmán, S</dc:creator>
<dc:creator>Jiménez Cruz, J. F</dc:creator>
<dc:creator>Palmero Martí, J. L</dc:creator>
<dc:creator>Budia Alba, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La afectación vesical en la amiloidosis es un hecho poco frecuente, pudiendo distinguir entre formas primarias de amiloidosis vesical y formas de amiloidosis sistémica con afectación vesical (amiloidosisvesical secundaria), lo cual es importante para el urólogo. Ésta constituye una entidad patológica muy infrecuente, en base a la escasez de referencias en la literatura (estimamos que el número de casos de amiloidosis vesical secundaria comunicado no supera los 20). El caso que presentamos corresponde a una amiloidosis vesical secundaria en el seno de una artritis reumatoide de larga evolución, que debutó con hematuria severa. Señalamos la importancia que la inmunohistoquímia representa para el diagnóstico (AU)</dc:description>
<dc:source>Actas Urol Esp;28(3): 238-242, mar. 2004. ilus</dc:source>
<dc:identifier>ibc-114091</dc:identifier>
<dc:title xml:lang="es">Amiloidosis vesical secundaria</dc:title>
<dc:subject>^d699^s22012</dc:subject>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d3576^s22045</dc:subject>
<dc:subject>^d3576^s22066</dc:subject>
<dc:subject>^d1768^s29166</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d699^s22032</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22921^s22074</dc:subject>
<dc:subject>^d23501^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d1770^s22053</dc:subject>
<dc:subject>^d1770^s29166</dc:subject>
<dc:subject>^d699^s29166</dc:subject>
<dc:subject>^d1768^s22053</dc:subject>
<dc:subject>^d6566^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d699^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200403</dc:date>
</metadata>
</record>
</ibecs-document>
